RecallHawk

CLONIDINE HYDROCHLORIDE

XIAMEN LP PHARM CO

Summary

FDA approved CLONIDINE HYDROCHLORIDE by XIAMEN LP PHARM CO. ANDA (Generic) approval (Labeling) on 2023-07-10. TABLET, EXTENDED RELEASE, ORAL.

Details

Source

Drug Approval

External ID

ANDA209757-2

Action Date

2023-07-10

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

CLONIDINE HYDROCHLORIDE, TABLET, EXTENDED RELEASE, ORAL. Application: ANDA209757

Context & Analysis

XIAMEN LP PHARM CO has 5 FDA actions in our database.

Frequently Asked Questions

How often does XIAMEN LP PHARM CO have FDA actions?

XIAMEN LP PHARM CO has 5 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA209757-2" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions